October 2010
BMJ GroupEpisode Description
More Episodes
-
0Nutritional peripheral neuropathies, with Dr. Alexander Rossor
-
0Distinguishing primary from functional tics
-
0Nitrous Oxide Abuse
-
0Brain Fog Demystified
-
0A roadmap to ALS prevention: strategies and priorities
-
0MOGAD: Definition, diagnosis and treatment
-
0CGRP in migraine: current therapeutics, future implications and potential off-target effects
-
0Alemtuzumab’s impact on functional and structural integrity of the visual system in MS
-
0Guidelines for the management of functional speech and communication disorders
-
0The impact of traumatic brain injury on neurocognitive outcomes in children
-
1Cerebral Microbleeds: from depiction to interpretation
-
0Motor functional neurological disease, a decade of progress
-
0COVID - 19 Vaccination and risk of large vessel arterial stroke
-
0Drug repurposing for progressive multiple sclerosis
-
0Isaacs syndrome the crossroads of Neurology, Psychiatry and Immunology
-
0Apathy, cerebral small vessel disease and future dementia risk
-
0Performance validity tests - Their role in neuropsychology assessments
-
0Parkinson’s disease: etiopathogenesis and treatment
-
0Outcome measurement in functional neurological disorder a systematic review and recommendations
-
0Clinical profiles of patients with dementia and chronic traumatic encephalopathy
-
0Visual hallucinations in neurological and ophthalmological disease
-
0Primary Lateral Sclerosis: new consensus criteria
-
0Neurology in the time of COVID - 19
-
0Lithium: a slow burner
-
2Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
-
0Multifocal motor neuropathy: controversies and priorities
-
0Multiple Systems Atrophy: the nature of the beast revisited
-
0Employment and MS - a patient’s perspective
-
0Approaches to Chemotherapy induced peripheral neurotoxicity
-
0Neural circuitry of anxiety
-
0Dementia after traumatic brain injury
-
0Mindfullness in multiple sclerosis
-
0CIDP an update
-
0Movement disorders and seizures
-
0The role of functional neuroimaging in functional neurological disorders
-
0Emotional processing in functional neurological disorder (FND)
-
0Can cocoa help with fatigue in MS
-
0Neurorehabilitation in chronic stroke
-
0The real patient value
-
0Medical conferences - what do we get out of them?
-
0Oral immunotherapies in MS a comparison of efficacy.
-
0Therapeutic trial design in frontotemporal dementias
-
0Do genes affect age of onset in ALS?
-
0The lifetime risk of common neurological disorders in the elderly population
-
0PMA and PLS: are they really restricted phenotypes?
-
0Statins and the risk of recurrent intracerebral haemorrhage (ICH) – what does the evidence say?
-
0Functional impairment and improvement
-
0Can computational models help us understand complex movement disorders?
-
0Idiopathic intracranial hypertension: guidelines for diagnosis and management
-
0Nusinersen for SMA
-
0Expanding clinical spectrums in both Kennedy’s disease and poststroke syndromes
-
0The use of cannabis in epilepsy, and surgery for tremor
-
0Epilepsy an evidence update
-
0Evolution or revolution? Should we re-think clinical practice?
-
0The Use of Frankincense Extract In MS
-
0A new questionnaire to measure quality of life in inflammatory neuropathies
-
0Marriage and a reduced risk of dementia
-
0Anti-inflammatory approaches to stroke prevention; monitoring disease progression in ALS
-
0Nodes and paranodes; alternative treatments in MS
-
0Pathophysiology of functional neurological disorder
-
0Is methamphetamine use linked to stroke in young adults?
-
0Cerebral Amyloid Angiopathy: New Insights For Clinical Practice
-
0Cortical Influences in ALS
-
0Intravenous immunoglobulin in CIDP
-
0Complex inherited neuropathies: a new approach to diagnosis?
-
0Cerebellum and neurodegeneration; autoantibodies and psychological development in children
-
0Time Matters - part 2: how the real costs of multiple sclerosis are being concealed
-
0Survival and cause of death in Multiple Sclerosis
-
0Time Matters - part 1: delay is “expensive” in all aspects of multiple sclerosis
-
0Seven tesla MRI In Neurodegenerative Dementias
-
0Conversational Laughter In Dementia
-
0Narrative and Neurology: The Andrew Lees Experiment
-
0April 2017: deconstructing dilemmas in Amyotrophic Lateral Sclerosis and Guillain-Barré Syndrome
-
0Zika virus and Guillain-Barré Syndrome: what do we know?
-
0Immunomodulatory therapy in advanced multiple sclerosis
-
0The relationship between orthostatic hypotension and cognitive impairment in α-synucleinopathies
-
0A clinical tool for predicting survival in motor neurone disease
-
0Latitude and disease severity in Multiple Sclerosis
-
0Do your kids play rugby? Risks for rugby union players from repeated concussions
-
0Genetics and the clinical course of multiple sclerosis
-
0Is it time to focus on the common pathways linking neurodegenerative diseases?
-
0October 2016 Edition: long-term outcomes after stroke; hereditary and inflammatory neuropathies
-
0Selective vulnerability in clinical variants of Alzheimer’s Disease
-
0Smoking: a negative prognostic for survival in motor neurone disease patients
-
0Review: Amyotrophic Lateral Sclerosis and Motor Neuron Syndromes in Asia
-
0Automated brain volumetrics in multiple sclerosis, plus migraine and psychiatric co-morbidities
-
0Coffee consumption and multiple sclerosis
-
0June Edition: Parkinson’s disease and the rate of ALS progression
-
0Sudden Unexpected Death in Epilepsy: basic mechanisms and implications for prevention
-
0Re-evaluating the treatment of acute optic neuritis
-
0BNPA 2015: Spatial Neglect
-
0BNPA 2015: New theories of memory systems and networks
-
0BNPA 2015: Phantom phenomena
-
0Clinical neurology: why this still matters in the 21st century
-
0Imaging outcomes for trials of remyelination in multiple sclerosis
-
0BNPA 2014: Oxytocin and social cognition
-
0BNPA 2014: Schizophrenia and cognition
-
0Advances in epilepsy surgery
-
0Brain atrophy and disability progression in multiple sclerosis patients
-
0BNPA 2014: Joint hypermobilty and autonomic hyperactivity
-
0BNPA 2014: Post-Ictal psychosis
-
0BNPA 2014: TREM2 variants and risk of dementia
-
0Neurosurgical procedures for psychiatric illness
-
0Can stress trigger Parkinson’s? And new criteria for frontotemporal dementia syndromes.
-
0HIV and multiple sclerosis: beginning to unravel a mystery
-
0BNPA 2014: Neuropsychiatry of social knowledge and moral motivation
-
0DBS in essential tremor, and genetic counselling for ALS
-
0Mortality and morbidity 15 years after hospital admission with mild head injury
-
0Informed decision making in MS, and the striatum in neurodegeneration
-
0BNPA special: Autoimmune encephalitis
-
0BNPA special: The prospects of a vaccine for Alzheimer’s disease
-
0An unusual variant of Guillain–Barré syndrome, and dopamine dysregulation syndrome
-
0BNPA special: Impulse control disorder in Parkinson’s
-
0Diagnosing and treating functional symptoms
-
0Solving the case, making the diagnosis: Neurology and detective writing
-
0Radiation for brain metastases, and the genetics of ischaemic stroke
-
0Education special: Headache
-
0Aggressive MS, and disappointment following deep brain stimulation for Parkinson’s
-
0Vitamin D, sunlight, and MS
-
0Education special: Neurogenetics update
-
0Diagnosing and treating neuromyelitis optica
-
0Diagnosing the dementias
-
0Anti-GQ1b antibody syndrome, and ALS and language deficits
-
0Striatal cell transplants for Huntington’s disease: where are we now?
-
0Education special: MS update
-
0Education special: Peripheral nerve disease update
-
0Stem cells in neurology, and enlarged perivascular spaces and intracerebral haemorrhage
-
0Parkinson’s disease subtypes: lost in translation?
-
0The latest on stroke
-
0Dopamine agonist withdrawal syndrome
-
0BNPA 2013: The impact of epilepsy on cognitive function
-
0BNPA 2013: Psychedelic drugs, magical thinking and psychosis
-
0BNPA 2013: Decoding consciousness
-
0BNPA 2013: Epilepsy, depression and anxiety disorders
-
0BNPA 2013: Brain networks in human epilepsy
-
0BNPA 2013: Cellular mechanisms of epilepsy
-
0BNPA 2013: Autoimmunity and neuropsychiatry
-
0BNPA 2013: Deep brain stimulation for mental illness
-
0BNPA 2013: The neural correlates of Freudian “repression” in conversion disorder
-
0BNPA 2013: Effects of early childhood posterior fossa tumours on IQ
-
0BNPA 2013: Epilepsy and affective disorders, the role of the subgenual prefrontal cortex
-
0BNPA 2013: Stress and war, and the limits of neuropsychiatry
-
0BNPA 2013: Childhood stress and risk for later mental disorder
-
0BNPA 2013: Inflammation and mental illness
-
0BNPA 2013: Posttraumatic stress disorder and the brain
-
0BNPA 2013: Equipped to survive, how comprehensive response to threat enables optimal behaviour
-
0Discovering Emery-Dreifuss muscular dystrophy, and flavour identification in FTLD
-
0The future of epilepsy research, assessing hemianopia, measuring sensory nerve action potentials
-
0The Scheltens scale, disability after head injury, and cannabis for multiple sclerosis
-
0Early days of the Queen Square brain bank; rating dopaminergic replacement therapy response
-
0Oliver Sacks’s functional paralysis; progressive multifocal leukoencephalopathy
-
0Recovery after stroke; malingering after concussion
-
0The future of glioblastoma therapy
-
0Neurological symptoms from autoimmune syndromes; movement disorders and OCD; counting strokes
-
0Idiopathic intracranial hypertension; discovering the neurological effects of critical illness
-
0Diagnostic criteria for CBS; tractography in ALS fifty years ago; better tests for bvFTD
-
0Surrogate outcomes; CAA and IH; Angela Vincent looks back
-
0Cerebral amyloid angiopathy; lifestyle and mortality after stroke; motor output patterns
-
0The early days of chronic fatigue syndrome research; Clues to functional weakness mechanism
-
0Diagnosing delirium
-
0Diagnosing conversion disorder; exercise to prevent falls in Parkinson’s patients
-
0The natural history of Parkinson’s; the latest on MS and latitude
-
0Athleticism and ALS; understanding peripherally induced movement disorders
-
0Thrombolysis for elderly stroke patients; disability with organically-unexplained symptoms
-
0Finger length ratio and ALS; psychotherapy for dizziness
-
0Frontotemporal dementia reviewed; temporal orientation and dementia
-
0Dementia and word knowledge; DBS for Parkinson’s
-
0Genes, vitamin D and MS; hysteria and hypnosis
-
0Eye movements in motor neurone disease; work and multiple sclerosis
-
0Predicting adjustment to an ALS diagnosis
-
0Microbleeds and abuse in dementia
-
0Migrane co-morbidities
-
0The SCAN rule
-
0Epilepsy and driving; Self awareness in dementia
-
0Pregnancy and MS
Comments (0)
0/500
New Comments(0)
What do you think of this episode?